Michaël Mellink is a Senior Partner in the Amsterdam office and Head of the Life Sciences Practice. He specialises in advising clients on board and senior level appointments for Pharma, Biotech, Medtech and Service companies. He works across international markets and a broad range of companies in Life Sciences. Prior to joining Odgers Berndtson, he worked for Cephalon, a U.S. biopharmaceutical company, where he was General Manager for Benelux operations and European Business Development. He has worked for Eli Lilly and Company in senior commercial and management positions. Michaël holds a Bachelor's degree in Physiotherapy and has studied Orthopaedic Medicine.